Emendo Biotherapeutics Raises $61 Million to Advance Next Generation Genome Editing Therapeutics

Funding & investments

Home » Funding & investments

Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences

Collaboration Brings Together Gilead’s Commitment to Advancing Cell Therapy with Kyverna’s Focus on Advanced T Cell Engineering Targeting Autoimmune Diseases Series A Investors Include Vida Ventures...

Codagenix Raises $20 Million in Series B Funding for Continued Development of RSV, Influenza and Oncolytic Virus Products

AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma

VANCOUVER, Wash., Jan. 13, 2020 /PRNewswire/ — AbSci, the Protein Printing™ company with a best-in-class E. coli cell line for rapid and low-cost biomanufacturing of complex biotherapeutics, today announced the...

DMC Biotech Total Series A Fundraising Closes With $11.3 Million

NovoNutrients Joins Chevron Technology Ventures’ Catalyst Program

Ask a VC

Turbine Secures €3 Million EUR Seed Fund to Expand the Potential of Simulation-first Drug Discovery

X-37 Announces $14.5 Million Series A

University of Birmingham spin-out secures £2m to develop medical diagnostic technology

eGenesis Announces $100 Million Series B Financing

Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by NEA and Announces the Formation of a World-Class Scientific Advisory Board, to Advance a First-in-Class RNA Editing Gene Therapy Platform Focused on Curing Genetic Diseases

TetraScience secures investment from Waters Corporation, joining Floodgate Capital, First Round, Underscore VC, Founder Collective and Y Combinator in $8M series A